NEVVI Medicare utilization intelligence
or

← back

Provider profile

MUELLER, JENNIFER MD

Dermatology · NPI 1972766152 · SINKING SPRING, PA

1
Groups
22
Codes · 2024
25,264
Disclosed services

MUELLER, JENNIFER is a Dermatology in SINKING SPRING, PA, a member of 1 medical group, who billed 22 distinct codes to Medicare Part B in 2024.

Groups: CLEAR DERMATOLOGY LLC (SINKING SPRING, PA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

25,264
disclosed services
22
codes billed to Medicare Part B
Prior year · CY2023 12,812 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17003 Destruction of precancer skin growth, 2-14 growths
11102 Biopsy of related skin growth, first growth
17000 Destruction of precancer skin growth, 1 growth
17110 Destruction of skin growth, 1-14 growths
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
96574 Application of light with debridement to destroy precancer skin growth
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
11103 Biopsy of related skin growth, each additional growth
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
11900 Injection into skin growth, 1-7 growths
11300 Shaving of skin growth of body, arms, or legs, 0.5 cm or less
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
11104 Punch biopsy, first skin growth
11305 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.